Pages that link to "Q43279735"

The following pages link to Relationship between rate of infusion and reinforcing strength of oxycodone in humans (Q43279735):

Displaying 19 items.

• Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain (Q30657653) (← links)
• Hepatitis C infection in non-treatment-seeking heroin users: the burden of cocaine injection (Q33760646) (← links)
• Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies (Q34126585) (← links)
• The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone (Q34661770) (← links)
• Impact of in-patient research participation on subsequent heroin use patterns: implications for ethics and public health (Q35909721) (← links)
• Tolerance and sensitization to chronic escalating dose heroin following extended withdrawal in Fischer rats: possible role of mu-opioid receptors (Q36389121) (← links)
• Assessment of a formulation designed to be crush-resistant in prescription opioid abusers (Q36845718) (← links)
• Pharmacokinetics, tolerability, and safety of intranasal administration of reformulated OxyContin(®) tablets compared with original OxyContin (®) tablets in healthy adults (Q36878225) (← links)
• A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers (Q36878938) (← links)
• Miotic and subject-rated effects of therapeutic doses of tapentadol, tramadol, and hydromorphone in occasional opioid users (Q36930408) (← links)
• Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects (Q36934062) (← links)
• A Randomized, Double-Blind, Double-Dummy Study to Evaluate the Intranasal Human Abuse Potential and Pharmacokinetics of a Novel Extended-Release Abuse-Deterrent Formulation of Oxycodone (Q36972164) (← links)
• Update on prescription extended-release opioids and appropriate patient selection (Q37053718) (← links)
• Characterizing the relationship between increases in the cost of nicotine and decreases in nicotine content in adult male rats: implications for tobacco regulation (Q49271444) (← links)
• Relative Bioavailability, Intranasal Abuse Potential, and Safety of Benzhydrocodone/Acetaminophen Compared with Hydrocodone Bitartrate/Acetaminophen in Recreational Drug Abusers (Q50100164) (← links)
• Pharmacokinetics and Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone, After Intranasal Administration in Recreational Drug Users. (Q50221689) (← links)
• Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic. (Q55022470) (← links)
• A Systematic Review of Laboratory Evidence for the Abuse Potential of Tramadol in Humans (Q90732575) (← links)
• Are Opioids Needed to Treat Chronic Low Back Pain? A Review of Treatment Options and Analgesics in Development (Q96304206) (← links)